CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment
/
DateDec 15 2022
REHOVOT, Israel, Dec. 15, 2022 /PRNewswire/ — CardiaCare, a clinical stage digital therapeutic company developing the world’s first non-invasive, personalized neuromodulation wearable for atrial fibrillation... Read More →
















